Position in RARE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,300,169
+$1,640,305 QoQ
Shares Held
157,526
+118.3% QoQ
Ownership
0.160%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
20 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RARE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MARSHALL WACE, LLP holds $2,764,425,276 across 279 Biotechnology names. RARE ranks #129 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,099,318 | $363,731,344 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
317,058 | $141,579,078 | |
| 3 | INCY |
Incyte Corp
|
1,253,138 | $117,945,347 | |
| 4 | RPRX |
Royalty Pharma plc
|
2,120,692 | $101,729,594 | |
| 5 | RCUS |
Arcus Biosciences, Inc.
|
3,761,437 | $81,247,039 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
628,075 | $66,199,104 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
2,246,943 | $62,240,320 | |
| 8 | COGT |
Cogent Biosciences, Inc.
|
1,600,168 | $61,590,466 |
All Filings in RARE
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,300,169 | 157,526 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $1,659,864 | 72,168 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $4,394,507 | 146,094 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $2,395,069 | 65,871 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $12,096,964 | 334,078 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $44,239,675 | 1,051,573 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $45,662,766 | 822,012 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $46,570,410 | 1,133,100 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $45,242,143 | 968,990 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $71,227,220 | 1,489,486 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $33,538,200 | 940,763 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $42,745,764 | 926,637 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $36,311,552 | 905,525 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $15,540,240 | 335,425 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $3,342,366 | 80,714 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $20,979,439 | 351,650 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $27,991,596 | 385,453 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $19,696,400 | 234,230 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $2,700,468 | 29,942 | Shares | Sole | 2021-11-15 | |
| 2020-12-31 | $3,601,118 | 26,014 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||